SCHEMBL21759155

SCHEMBL21759155

CCn1cnc(-c2ccc(F)cc2)c1-c1ccc2ncc(C)n2n1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 20/20 0.74
TGFBR2 P37173 9/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18057167 0.90 TGFBR1 (0.77) TGFBR1TGFBR2
SCHEMBL21759112 0.89 TGFBR1 (0.73) TGFBR1TGFBR2
SCHEMBL21759212 0.88 TGFBR1 (0.74) TGFBR1TGFBR2
SCHEMBL21759138 0.86 TGFBR1 (0.74) TGFBR1TGFBR2
SCHEMBL21759139 0.85 TGFBR1 (0.76) TGFBR1TGFBR2
SCHEMBL21759080 0.85 TGFBR1 (0.69) TGFBR1TGFBR2
SCHEMBL18041910 0.85 TGFBR1 (1.00) TGFBR1TGFBR2
SCHEMBL21759288 0.85 TGFBR1 (0.72) TGFBR1TGFBR2
SCHEMBL21759094 0.84 TGFBR1 (0.77) TGFBR1TGFBR2
SCHEMBL18041565 0.84 TGFBR1 (0.83) TGFBR1TGFBR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3265454-B1 TGF-BETA INHIBITORS RIGEL PHARMACEUTICALS INC (US) 2020-02-26 EP disclosed